NCT00125541View on ClinicalTrials.gov

C1-Esteraseremmer-N for the Treatment of Hereditary (and Acquired) Angioedema

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

April 30, 2008

Study Completion Date

May 31, 2008

Conditions
Angioedema
Interventions
DRUG

C1 inhibitor concentrate (C1-esteraseremmer-N)

every 5-7 days

Trial Locations (1)

1100 DD

Academic Medical Centre, Amsterdam

Sponsors
All Listed Sponsors
lead

Prothya Biosolutions

INDUSTRY